Cargando…

Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis

SIMPLE SUMMARY: Colorectal cancer is the second most common cancer worldwide, and the incidence increases with age. The primary treatment for localized disease is surgical resection. Biomarkers identifying older patients at risk of complications following surgery are desirable to create a more indiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dolin, Troels Gammeltoft, Christensen, Ib Jarle, Johansen, Astrid Zedlitz, Nielsen, Hans Jørgen, Jakobsen, Henrik Loft, Klein, Mads Falk, Lund, Cecilia Margareta, Bojesen, Stig Egil, Nielsen, Dorte Lisbeth, Jensen, Benny Vittrup, Johansen, Julia Sidenius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750535/ https://www.ncbi.nlm.nih.gov/pubmed/35008324 http://dx.doi.org/10.3390/cancers14010161

Ejemplares similares

The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)
por: Lund, Cecilia Margareta, et al.
Publicado: (2021)

Circulating VEGF As a Biological Marker in Patients with Rheumatoid Arthritis? Preanalytical and Biological Variability in Healthy Persons and in Patients
por: Hetland, Merete Lund, et al.
Publicado: (2008)

AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival
por: Kemp Jacobsen, Katja, et al.
Publicado: (2019)

A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC)
por: Theile, Susann, et al.
Publicado: (2022)

MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability
por: Boisen, Mogens Karsbøl, et al.
Publicado: (2015)

Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer
por: Schou, Jakob Vasehus, et al.
Publicado: (2016)

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
por: Lindgaard, Sidsel C., et al.
Publicado: (2022)

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
por: Demuth, Christina, et al.
Publicado: (2018)

Geriatric assessment and intervention in older vulnerable patients undergoing surgery for colorectal cancer: a protocol for a randomised controlled trial (GEPOC trial)
por: Dolin, Troels G., et al.
Publicado: (2021)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Exercise in older women with breast cancer during systemic therapy: study protocol of a randomised controlled trial (BREACE)
por: Andersen, Høgni Hammershaimb, et al.
Publicado: (2020)

Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer
por: Lindgaard, Sidsel C., et al.
Publicado: (2022)

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma
por: Rasmussen, Louise, et al.
Publicado: (2020)

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer
por: Palshof, Jesper Andreas, et al.
Publicado: (2020)

Wnt5a expression and prognosis in stage II–III colon cancer
por: Lund, Cecilia Margareta, et al.
Publicado: (2020)

Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization – Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL) - study protocol of a randomized controlled trial
por: Mikkelsen, Marta Kramer, et al.
Publicado: (2018)

Cathepsin X in serum from patients with colorectal cancer: relation to prognosis
por: Vizin, Tjasa, et al.
Publicado: (2012)

Changes in Plasma IL-6, Plasma VEGF and Serum YKL-40 During Treatment with Etanercept and Methotrexate or Etanercept Alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy
por: Knudsen, Lene Surland, et al.
Publicado: (2009)

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer
por: Schultz, Nicolai A., et al.
Publicado: (2013)

Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients
por: Vižin, Tjaša, et al.
Publicado: (2014)

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017)

Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay
por: Christensen, Troels D., et al.
Publicado: (2022)

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
por: Skougaard, Kristin, et al.
Publicado: (2014)

Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer
por: Kjaergaard, Alisa D., et al.
Publicado: (2021)

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma
por: Stubbe, Benjamin Emil, et al.
Publicado: (2023)

An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort
por: Smith, David Hersi, et al.
Publicado: (2013)

Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study
por: Kringelbach, Tina Marie, et al.
Publicado: (2018)

Data fusion in metabolomic cancer diagnostics
por: Bro, Rasmus, et al.
Publicado: (2012)

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
por: Palshof, Jesper Andreas, et al.
Publicado: (2017)

Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung Cancer
por: Johansen, Astrid Zedlitz, et al.
Publicado: (2022)

Combined plasma C‐reactive protein, interleukin 6 and YKL‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer
por: Videmark, Alex N., et al.
Publicado: (2022)

The Impact of Psychosexual Counseling in Women With Lichen Sclerosus: A Randomized Controlled Trial
por: Vittrup, Gitte, et al.
Publicado: (2022)

Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer
por: Illemann, Martin, et al.
Publicado: (2014)

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
por: Nielsen, Boye Schnack, et al.
Publicado: (2010)

Gene expression profiling of meningiomas: current status after a decade of microarray-based transcriptomic studies
por: Aarhus, Mads, et al.
Publicado: (2011)

COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis
por: Holmstroem, Rikke Boedker, et al.
Publicado: (2022)

Antisense Gene Silencing: Therapy for Neurodegenerative Disorders?
por: Nielsen, Troels T., et al.
Publicado: (2013)

Machine learning and deep learning applications in microbiome research
por: Hernández Medina, Ricardo, et al.
Publicado: (2022)

Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals
por: Pedersen, Kasper Mønsted, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1v4uh16k7f4k0dl0p2bk1umsv8